Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CapsCanada Adds New Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

CapsCanada Adds New Facility

The dedicated hydroxypropyl methylcellulose (HPMC) capsule manufacturing facility will increase output by 50%

By: Betsy Louda

, Contract Pharma

CapsCanada, a leading provider of capsules for pharmaceutical drugs and dietary supplements, announced the addition of a new, state-of-the-art, dedicated hydroxypropyl methylcellulose (HPMC) capsule manufacturing facility. 

 

With this investment, CapsCanada has now increased capsule output by 50%. Produced with 100% plant-derived material, CapsCanada’s K-CAPS® are ideal for consumers with dietary restrictions prohibiting the consumption of animal byproduct and are suitable for a wide range of formulations.

 

“The new factory was built because we saw worldwide acceptance of K-CAPS® as the preferred HPMC based capsule. Compared to other HPMC capsules, K-CAPS® have exceptional aesthetics and perform better on automatic capsule filling machines; directly translating into reduced raw material loss and downtime for our customers.” According to Jonathan Gilinski, executive director.

 

The company previously made a $10 million expansion of their Windsor, Ontario site in 2014, experiencing growing global demand for its products. K-CAPS® are already sold in more than 60 countries worldwide.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics